Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum periostin measurement study in severe oral corticosteroid-dependent asthma
2013-000900-41Phase 2Completed
- Sponsor
- Roche
- Start
- Apr 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of prednisolone in asthma, sponsored by Roche. Primary endpoint: Baseline serum periostin level. Started Apr 2013; status: completed.
02
Drugs
prednisolone
03
Conditions
asthma
Beyond the preview
Go deeper on 2013-000900-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000900-41.